Unusual Clinical Manifestation of Rheumatoid Arthritis. Clinical case [Manifestación Clínica Inusual de Artritis Reumatoide. Caso clínico]
DOI:
https://doi.org/10.62574/mm0swf59Keywords:
Felty syndrome, rheumatoid arthritis, neutropeniaAbstract
Objective: to present a clinical case of an unusual manifestation of rheumatoid arthritis. Method: Clinical case. Conclusion: The atypical clinical presentation with recurrent fever, hepatosplenomegaly, and cytopenias can mimic other conditions such as myelodysplastic syndrome, tuberculosis, or haematological neoplasms, requiring a thorough differential diagnosis in which elevated β₂-microglobulin (13.3 mg/L) and bone marrow examination are essential for confirming the diagnosis.
Downloads
References
Ren H, Wei G, Kong Z, Zhang M, Li Y, Liu S, et al. METTL3-mediated methylation of RAC2 contributes to cell motility, oxidative stress and inflammation in TNF-α-stimulated rheumatoid arthritis fibroblast-like synovial cells. J Orthop Surg Res. 2025 Feb 20 [citado 2025 Mar 10];20(1):180. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39980031/.
Emerson D, Merriman E, Yachi PP. Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells. Front Immunol. 2025 [citado 2025 Mar 10];16. Disponible en: https://pubmed.ncbi.nlm.nih.gov/39981237/.
Asgari N, Ghaemi EA, Tavasoli S, Aghaei M, Nikoo HR, Zamani S. Exploring the association between Mycobacterium avium subspecies paratuberculosis infection and rheumatoid arthritis: an immunological perspective. Arthritis Res Ther. 2025 Dec 1 [citado 2025 Mar 10];27(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/39985098/.
Lee J, Min HK, Lim JY, Song YS, Jeon JH, Jang SG, et al. Human nasal turbinate stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis. Sci Rep. 2025 Dec 1 [citado 2025 Mar 10];15(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/39987230/.
Gholizadeh M, Asadi J, Aghaei M, Akbar S, Malakouti R, Sepehr KS, et al. The evaluation of PNPLA2, ATGL, and G0S2 levels in serum and PBMCs of the newly diagnosed and the chronic patients with rheumatoid arthritis. Int J Rheum Dis. 2025 Feb 1 [citado 2025 Mar 10];28(2). Disponible en: https://pubmed.ncbi.nlm.nih.gov/39989302/.
Alvillar RE, Grady LO, Robbins D. Coexistent Felty’s syndrome and palindromic rheumatism. Ann Rheum Dis. 1991 [citado 2025 Mar 10];50(12):953-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/1768169/.
Li RC, Xu WD, Liu XY, Fu L, Lan YY, Feng SY, et al. A risk prediction model for the development of rheumatoid arthritis, Sjögren’s syndrome, systemic sclerosis in patients with systemic lupus erythematosus: multicenter approaches. Int J Rheum Dis. 2025 Feb 1 [citado 2025 Mar 10];28(2). Disponible en: https://pubmed.ncbi.nlm.nih.gov/39995057/.
Bergmans B, Roks G, van Puijenbroek E, de Vries E, Murk JL. Progressive multifocal leukoencephalopathy in rheumatoid arthritis and biological therapies: a case report and review of the literature. J Med Case Rep. 2025 Dec 1 [citado 2025 Mar 10];19(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/39994658/.
Dogru A, Gur Hatip F. Autoimmune thyroid disease and Sjögren disease: organ-specific disease triggered by systemic autoimmunity? Medicina (Kaunas). 2025 Feb 1 [citado 2025 Mar 10];61(2). Disponible en: https://pubmed.ncbi.nlm.nih.gov/40005404/.
Li Y, Cai M, Qin Y, Dai X, Liang L, Li Z, et al. MTHFD2 promotes osteoclastogenesis and bone loss in rheumatoid arthritis by enhancing CKMT1-mediated oxidative phosphorylation. BMC Med. 2025 Dec 1 [citado 2025 Mar 10];23(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/40016725/.
Ahijón Lana M, Sivera Mascaró F, Fernández-Nebro A, Muntadas Castelló S, Pérez M, Otón T, et al. EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis. RMD Open. 2025 Jan 27 [citado 2025 Mar 10];11(1):e004989. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40021204/.
Chen S, Li X, Shen Y, Lin S, Shui X, Zhu H. BMSC-derived exosomes improve rheumatoid arthritis by regulating Th17 cell differentiation through targeting PRDM1. Regen Med. 2025 Jan 2 [citado 2025 Mar 10];20(1):35-44. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40022525/.
Huang L, Zhou Y, Liu Y, Xu P, Deng X. Medication adherence and illness perception in patients with rheumatoid arthritis: the mediating effect of self-efficacy. J Musculoskelet Neuronal Interact. 2025 Mar 1 [citado 2025 Mar 10];25(1):101-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40024233/.
Liu L, Ambe K, Onishi M, Yoshii Y, Makino T, Tohkin M. Comparison of the efficacy and safety of disease-modifying antirheumatic drugs combination therapies: a systematic review and network meta-analysis. Clin Transl Sci. 2025 Mar 1 [citado 2025 Mar 10];18(3). Disponible en: https://pubmed.ncbi.nlm.nih.gov/40033744/.
Mariette X, Borchmann S, Aspeslagh S, Szekanecz Z, Charles-Schoeman C, Schreiber S, et al. Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes. RMD Open. 2025 Jan 4 [citado 2025 Mar 10];11(1):e005033. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40037922/.
Wang L, Hao M, Xu Y, Wang Z, Xie H, Zhang B, et al. Adipose-derived stem cells attenuate rheumatoid arthritis by restoring CX3CR1+ synovial lining macrophage barrier. Stem Cell Res Ther. 2025 Mar 5 [citado 2025 Mar 10];16(1):111. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40038808/.
Weinblatt ME, Taylor PC, McInnes IB, Atsumi T, Strand V, Takeuchi T, et al. Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X). BMJ Open. 2025 Mar 5 [citado 2025 Mar 10];15(3):e088869. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40044198/.
Jiang P, Zhao Y, Jia Y, Ma H, Guo Y, Yan W, et al. Multi-omics study on autophagic dysfunction molecular network in the pathogenesis of rheumatoid arthritis. J Transl Med. 2025 Mar 5 [citado 2025 Mar 10];23(1):274. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40045304/.
Zhu X, Lu H, Jia H, Wei X, Xue J, Li W, et al. Ferrostatin-1 reduces the inflammatory response of rheumatoid arthritis by decreasing the antigen presenting function of fibroblast-like synoviocytes. J Transl Med. 2025 Mar 6 [citado 2025 Mar 10];23(1):280. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40050869/.
Sun H, Miao J, Zhang K, Zhang P, Shen H, Wang J, et al. Id2 exacerbates the development of rheumatoid arthritis by increasing IFN-γ production in CD4+ T cells. Clin Transl Med. 2025 Mar [citado 2025 Mar 10];15(3):e70242. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40051059/.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Luis David Supe-Salazar, Brayan Stiven Gualpa-Peralta, Luis David Torres-Villa, María Augusta Reyes-Pérez (Autor/a)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
